BioEclosion
PrivateLast Round
Seed
Dec 1, 2024
Est. Valuation
$2.96M
Total Funding Raised
$1.22M
Company Overview
BioEclosion operates in Healthcare & Life Sciences and is based in Cerdanyola del Vallès. Its latest recorded funding round was a Seed round in December 2024.
BioEclosion is a healthtech company that develops a patented in-vitro diagnostic device for rapid diagnostics in human health, veterinary, and food safety.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Sensors, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioEclosion Comparables
Compare BioEclosion with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Embio Diagnostics | 82% | |
| Guanine Inc. | 78% | |
| StataDx, Inc. | 78% |
For institutional investors. Book with your work email.
BioEclosion Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 1, 2024 | ||||
| Grant | Apr 5, 2023 | ||||
| Accelerator | May 17, 2021 | ||||
| Grant | Dec 1, 2020 | ||||
| Grant | Oct 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioEclosion Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| S2 Xpeed | Seed |
| Fundación la Caixa | Grant |
| Center for Technological Development and Innovation | Grant |
| MassChallenge Switzerland | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 17, 2021
Participated in MassChallenge Switzerland's accelerator program.
- Dec 1, 2020
$114K grant received from Fundación la Caixa.
For institutional investors. Book with your work email.
BioEclosion Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioEclosion's valuation, stock price, and market status.
Is BioEclosion a public or private company?
BioEclosion is a private company.
What is the current stock price of BioEclosion?
BioEclosion is a private company, so its shares have no public market price. Caplight tracks BioEclosion's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioEclosion worth (valuation)?
BioEclosion's valuation is estimated at $3.0M based on funding round data.
Can I buy BioEclosion stock?
BioEclosion shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioEclosion's last funding round?
BioEclosion's most recent funding round was Seed on December 1, 2024.
Who are the main investors in BioEclosion?
Key investors in BioEclosion include S2 Xpeed, Fundación la Caixa, Center for Technological Development and Innovation, MassChallenge Switzerland.
Will BioEclosion IPO soon?
No public IPO plans have been announced for BioEclosion.
How can I track BioEclosion secondary market activity?
Caplight tracks bids, offers, and trades in BioEclosion's shares on secondary markets.